These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 786170)

  • 41. [Lichen ruber planus and lichen ruber verrucosus of the skin: therapeutic results using vitamin A acid in 98 patients].
    Günther S
    Z Hautkr; 1975 Jan; 50(2):59-68. PubMed ID: 818834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Generalized pustular psoriasis (Zumbusch). Remarkable effect of a vitamin A acid ester administered per os].
    Chandon JP; Devaux JF; Gamby T; Privat Y
    Nouv Presse Med; 1978 Dec; 7(46):4234-5. PubMed ID: 745969
    [No Abstract]   [Full Text] [Related]  

  • 46. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
    Queille-Roussel C; Duteil L; Parneix-Spake A; Arsonnaud S; Rizova E
    Eur J Dermatol; 2001; 11(3):219-24. PubMed ID: 11358728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis.
    Katoh N; Kishimoto S
    Eur J Dermatol; 2003; 13(4):382-4. PubMed ID: 12948920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral treatment of psoriasis and pustulosis palmo-plantaris with Ro 10-9359.
    Fredriksson T
    Dermatologica; 1978; 157 Suppl 1():13-8. PubMed ID: 150982
    [No Abstract]   [Full Text] [Related]  

  • 50. Calcitriol ointment: optimizing psoriasis therapy.
    Gold LF
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticosteroids: options in the era of steroid-sparing therapy.
    Del Rosso J; Friedlander SF
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S50-8. PubMed ID: 15968264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis.
    Kosari P; Feldman SR
    Dermatol Online J; 2009 Mar; 15(3):15. PubMed ID: 19379659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
    Ruzicka T; Sommerburg C; Braun-Falco O; Köster W; Lengen W; Lensing W; Letzel H; Meigel WN; Paul E; Przybilla B
    Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
    Lebwohl MG; Tan MH; Meador SL; Singer G
    J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
    Engel MF
    Cutis; 1982 Jun; 29(6):646-50. PubMed ID: 7049592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New developments in topical sequential therapy for psoriasis.
    Koo JY
    Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
    Durakovic C; Ray S; Holick MF
    Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris.
    Abe M; Syuto T; Hasegawa M; Sogabe Y; Yokoyama Y; Ishikawa O
    J Dermatol; 2006 Feb; 33(2):108-11. PubMed ID: 16556277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on the effect of desoximetason-- a new local corticosteroid preparation].
    Konzelmann H; Much T; Schwarz K
    Schweiz Rundsch Med Prax; 1974 Jul; 63(28):878-81. PubMed ID: 4277933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.